Protego Biopharma
PrivateLast Round
Series B
Dec 1, 2025
Total Funding Raised
$181M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Protego Biopharma is a biotechnology company that develops a small molecule therapeutics platform aimed at reprogramming protein folding to treat systemic amyloid diseases and other protein misfolding disorders.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Protego Biopharma Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Protego Biopharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 1, 2025 | ||||
| Series A | Nov 17, 2021 |
Key People
Founding team and executive leadership
Protego Biopharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MPM Capital | Seed, Series A |
| Omega Funds | Series B |
| Forbion | Series B |
| Digitalis Ventures | Series B |
| Vida Ventures | Series B, Series A |
| MPM BioImpact | Series B |
| Droia Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 27, 2026
Open roles increased to 12, representing 50% of headcount.
- Mar 3, 2026
John M. Maraganore appointed to the Board of Directors.
Protego Biopharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Protego Biopharma's valuation, stock price, and market status.